Vaccine Supplier-Buyer Network — Trade Flow Analysis

Name: Vaccine Supplier-Buyer Trade Network Dataset — 325+ Indian Exporters, 21+ Importers, 192+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Vaccine supplier network, Vaccine buyers, pharmaceutical export India, Vaccine trade data

TransData Nexus

Vaccine

India Pharmaceutical Trade Intelligence

$1.0B325 Suppliers192 CountriesHS 30024200

ExportsIndia → PAKISTAN8.5%India → NIGERIA8.1%

ImportsFRANCE → India$176.5B GERMANY → India$138.0B

#1 Supplier: SERUM INSTITUTE

Who Supplies Vaccine? Top Manufacturers & Buyers 2026 — SERUM INSTITUTE OF INDIA PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1SERUM INSTITUTE OF INDIA PRIVATE LIMITED

SERUM INSTITUTE OF INDIA PRIVATE LIMITED is the first-largest Vaccine exporter from India, with a market share of 12.8% and a total export value of $133.0M across 3.2K shipments. Their average shipment value of $41.2K is below the market average of $72.5K, reflecting a high-volume, competitive pricing strategy.

SERUM INSTITUTE OF INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXRUMXXIFEXXCIEXXES XXD — $31.3M across 760 shipments (23.6% of this supplier's total exports)

• SERUM LIFE SCIENCES LTD — $31.3M across 760 shipments (23.6% of this supplier's total exports)

• UNICEF SUPPLY DIVISION — $26.8M across 650 shipments (20.2% of this supplier's total exports)

• XXICEXXSUPXXY DXXISIXX — $23.5M across 569 shipments (17.7% of this supplier's total exports)

• SERUM LIFE SCIENCES LTD — $20.0M across 486 shipments (15.1% of this supplier's total exports)

Key Insight: SERUM INSTITUTE OF INDIA PRIVATE LIMITED operates with high shipment frequency (3.2K shipments) at a per-shipment value of $41.2K, indicating a broad distribution network with many smaller, regular orders.

2BHARAT BIOTECH INTERNATIONAL LIMITED

BHARAT BIOTECH INTERNATIONAL LIMITED is the second-largest Vaccine exporter from India, with a market share of 8.0% and a total export value of $83.0M across 609 shipments. Their average shipment value of $136.2K is above the market average of $72.5K, suggesting premium or bulk contract pricing.

BHARAT BIOTECH INTERNATIONAL LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NATIONAL VACCINES AND IMMUNIZATION — $37.8M across 278 shipments (45.6% of this supplier's total exports)

• EXPANDED PROGRAM ON IMMUNIZATION — $14.6M across 107 shipments (17.6% of this supplier's total exports)

• PT BIO FARMA PERSERO NA — $12.0M across 88 shipments (14.5% of this supplier's total exports)

• NATIONAL PRIMARY HEALTHCARE — $9.4M across 69 shipments (11.4% of this supplier's total exports)

• PT BIO FARMA (PERSER — $9.1M across 67 shipments (10.9% of this supplier's total exports)

Key Insight: BHARAT BIOTECH INTERNATIONAL LIMITED's per-shipment value of $136.2K is 88% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.

3BIOLOGICAL E. LIMITED

BIOLOGICAL E. LIMITED is the third-largest Vaccine exporter from India, with a market share of 6.8% and a total export value of $70.5M across 859 shipments. Their average shipment value of $82.1K is above the market average of $72.5K, suggesting premium or bulk contract pricing.

BIOLOGICAL E. LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• D.G. CENTRAL MEDICAL STORES DEPT. — $33.0M across 402 shipments (46.8% of this supplier's total exports)

• EXPANDED PROGRAM ON IMMUNIZATION — $13.7M across 166 shipments (19.4% of this supplier's total exports)

• EXPANDED PROGRAMME ON IMMUNIZATION — $8.8M across 107 shipments (12.4% of this supplier's total exports)

• NATIONAL PRIMARY HEALTHCARE — $8.2M across 100 shipments (11.6% of this supplier's total exports)

• NATIONAL PRIMARY HEALTHCARE — $6.9M across 84 shipments (9.8% of this supplier's total exports)

Key Insight: BIOLOGICAL E. LIMITED's per-shipment value of $82.1K is 13% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.

4BIOLOGICAL E LIMITED

BIOLOGICAL E LIMITED is the fourth-largest Vaccine exporter from India, with a market share of 3.2% and a total export value of $33.3M across 313 shipments. Their average shipment value of $106.3K is above the market average of $72.5K, suggesting premium or bulk contract pricing.

BIOLOGICAL E LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BE VACCINES PTE LIMITED — $10.1M across 95 shipments (30.3% of this supplier's total exports)

• XX VAXXINEXXPTEXXIMI — $7.8M across 74 shipments (23.6% of this supplier's total exports)

• MINISTRY OF HEALTH — $6.1M across 57 shipments (18.3% of this supplier's total exports)

• D.G. CENTRAL MEDICAL STORES DEPT. — $5.0M across 47 shipments (15.1% of this supplier's total exports)

• FEDERAL MINISTRY OF — $4.2M across 40 shipments (12.7% of this supplier's total exports)

Key Insight: BIOLOGICAL E LIMITED's per-shipment value of $106.3K is 47% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.

5INDIAN IMMUNOLOGICALS LIMITED

INDIAN IMMUNOLOGICALS LIMITED is the fifth-largest Vaccine exporter from India, with a market share of 3.0% and a total export value of $31.5M across 403 shipments. Their average shipment value of $78.1K is above the market average of $72.5K, suggesting premium or bulk contract pricing.

INDIAN IMMUNOLOGICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CENTURION ILAC SANAYI VE TICARET AN — $11.6M across 149 shipments (37.0% of this supplier's total exports)

• 2 WORLD TRADERS INC — $9.9M across 127 shipments (31.5% of this supplier's total exports)

• DUC MINH MEDICAL JOI — $5.6M across 72 shipments (17.8% of this supplier's total exports)

• CENTURION ILAC SANAYI VE TICARET AN — $3.1M across 39 shipments (9.7% of this supplier's total exports)

• 2 WORLD TRADERS INC — $1.3M across 16 shipments (4.0% of this supplier's total exports)

Key Insight: INDIAN IMMUNOLOGICALS LIMITED's per-shipment value of $78.1K is 8% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.

6PANACEA BIOTEC LIMITED

PANACEA BIOTEC LIMITED is the fifth-largest Vaccine exporter from India, with a market share of 1.9% and a total export value of $19.8M across 234 shipments. Their average shipment value of $84.7K is above the market average of $72.5K, suggesting premium or bulk contract pricing.

PANACEA BIOTEC LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• D.G. CENTRAL MEDICAL STORES DEPT. — $7.2M across 85 shipments (36.2% of this supplier's total exports)

• D.G. CENTRAL MEDICAL STORES DEPT. — $4.8M across 56 shipments (24.1% of this supplier's total exports)

• PT BANK MANDIRI (PER — $2.8M across 33 shipments (14.0% of this supplier's total exports)

• MINISTERIO DA SAUDE/ — $2.6M across 31 shipments (13.4% of this supplier's total exports)

• UNICEF KABUL — $2.4M across 29 shipments (12.3% of this supplier's total exports)

Key Insight: PANACEA BIOTEC LIMITED's per-shipment value of $84.7K is 17% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.

1Pakistan

Pakistan ranks as the first-largest destination for Vaccine imports from India, with a total trade value of $88.1M across 105 shipments — representing a 8.5% share of all Vaccine exports. The average shipment value of $838.7K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Vaccine importers in Pakistan: EXPANDED PROGRAM ON IMMUNIZATION is the largest buyer, accounting for 37.9% ($33.4M) of this market's total imports.

• EXPANDED PROGRAM ON IMMUNIZATION — $33.4M (37.9% of Pakistan's total)

• EXPANDED PROGRAMME ON IMMUNIZATION — $14.0M (15.9% of Pakistan's total)

• BE VACCINES PTE LIMITED — $10.1M (11.5% of Pakistan's total)

Key Insight: Pakistan's per-shipment average of $838.7K (1056% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Pakistan is a key market for Vaccine imports from India.

Primary Market

Secondary Market

2Nigeria

Nigeria ranks as the second-largest destination for Vaccine imports from India, with a total trade value of $84.5M across 156 shipments — representing a 8.1% share of all Vaccine exports. The average shipment value of $541.8K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Vaccine importers in Nigeria: NATIONAL PRIMARY HEALTH CARE is the largest buyer, accounting for 58.3% ($49.3M) of this market's total imports.

• NATIONAL PRIMARY HEALTH CARE — $49.3M (58.3% of Nigeria's total)

• NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY NPHCDA — $9.4M (11.1% of Nigeria's total)

• NATIONAL PRIMARY HEALTHCARE — $9.3M (11.0% of Nigeria's total)

Key Insight: Nigeria's per-shipment average of $541.8K (647% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Vaccine imports from India.

Primary Market

Secondary Market

3Bangladesh

Bangladesh ranks as the third-largest destination for Vaccine imports from India, with a total trade value of $78.1M across 107 shipments — representing a 7.5% share of all Vaccine exports. The average shipment value of $730.0K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Vaccine importers in Bangladesh: D.G. CENTRAL MEDICAL STORES DEPT is the largest buyer, accounting for 47.7% ($37.2M) of this market's total imports.

• D.G. CENTRAL MEDICAL STORES DEPT — $37.2M (47.7% of Bangladesh's total)

• D G CENTRAL MEDICAL STORES DEPT — $11.8M (15.1% of Bangladesh's total)

• D.G. CENTRAL MEDICAL STORES DEPT. — $9.9M (12.6% of Bangladesh's total)

Key Insight: Bangladesh's per-shipment average of $730.0K (906% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Bangladesh is a key market for Vaccine imports from India.

Primary Market

Secondary Market

4Kenya

Kenya ranks as the fourth-largest destination for Vaccine imports from India, with a total trade value of $55.9M across 37 shipments — representing a 5.4% share of all Vaccine exports. The average shipment value of $1.5M is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Vaccine importers in Kenya: NATIONAL VACCINES AND IMMUNIZATION is the largest buyer, accounting for 69.2% ($38.7M) of this market's total imports.

• NATIONAL VACCINES AND IMMUNIZATION — $38.7M (69.2% of Kenya's total)

Key Insight: Kenya's per-shipment average of $1.5M (1984% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Vaccine imports from India.

Primary Market

Secondary Market

5Philippines

Philippines ranks as the fifth-largest destination for Vaccine imports from India, with a total trade value of $47.3M across 33 shipments — representing a 4.5% share of all Vaccine exports. The average shipment value of $1.4M is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Vaccine importers in Philippines: 2 WORLD TRADERS INC is the largest buyer, accounting for 23.2% ($11.0M) of this market's total imports.

• 2 WORLD TRADERS INC — $11.0M (23.2% of Philippines's total)

Key Insight: Philippines's per-shipment average of $1.4M (1876% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Vaccine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Vaccine.
2.Flow Mapping: 325 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 14,355 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 192 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

14,355 Verified Shipments

325 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Vaccine

Vaccine

Who Supplies Vaccine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Vaccine — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Vaccine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Vaccine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SERUM INSTITUTE OF INDIA PRIVATE LIMITED

2BHARAT BIOTECH INTERNATIONAL LIMITED

3BIOLOGICAL E. LIMITED

4BIOLOGICAL E LIMITED

5INDIAN IMMUNOLOGICALS LIMITED

6PANACEA BIOTEC LIMITED

From Indian Factories to Global Pharmacies — How Vaccine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Vaccine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Pakistan

2Nigeria

3Bangladesh

4Kenya

5Philippines

People Also Ask — Vaccine Supplier & Trade Network

Vaccine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology